236 related articles for article (PubMed ID: 22790638)
21. Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.
Mohamedbhai SG; Sibson K; Marafioti T; Kayani I; Lowry L; Goldstone AH; Linch DC; Ardeshna KM
Br J Haematol; 2011 Jan; 152(2):175-81. PubMed ID: 21092025
[TBL] [Abstract][Full Text] [Related]
22. Fatal reactivation of hepatitis B after chemotherapy for lymphoma.
Dillon R; Hirschfield GM; Allison ME; Rege KP
BMJ; 2008 Jul; 337():a423. PubMed ID: 18595895
[No Abstract] [Full Text] [Related]
23. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
[TBL] [Abstract][Full Text] [Related]
24. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
[TBL] [Abstract][Full Text] [Related]
25. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
26. Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study.
Rigacci L; Nassi L; Alterini R; Carrai V; Longo G; Bernardi F; Martini V; Bosi A
Acta Haematol; 2006; 115(1-2):22-7. PubMed ID: 16424645
[TBL] [Abstract][Full Text] [Related]
27. [Successful Prophylactic Minocycline Treatment for Recurrent Helicobacter Cinaedi Sepsis during Chemotherapy in a Patient with Follicular Lymphoma].
Aota Y; Gotoh A; Nakamura I; Motoya K; Okuda Y; Hanyu N; Honma T; Udou R; Yokoyama T; Kitagawa N; Komatsu N
Gan To Kagaku Ryoho; 2017 May; 44(5):433-435. PubMed ID: 28536343
[TBL] [Abstract][Full Text] [Related]
28. Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
Furman RR; Martin P; Ruan J; Cheung YK; Vose JM; LaCasce AS; Elstrom R; Coleman M; Leonard JP
Cancer; 2010 Dec; 116(23):5432-9. PubMed ID: 20665890
[TBL] [Abstract][Full Text] [Related]
29. Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis.
Lee L; Crump M; Khor S; Hoch JS; Luo J; Bremner K; Krahn M; Hodgson DC
Br J Haematol; 2012 Aug; 158(4):481-8. PubMed ID: 22671571
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and bacteriological examination in hospital of Helicobacter cinaedi (H. cinaedi)].
Kawakami Y
Kansenshogaku Zasshi; 2014 Jul; 88(4):417-22. PubMed ID: 25199374
[TBL] [Abstract][Full Text] [Related]
31. Neutropenic fever following chemotherapy in a patient with lymphoma.
Book L
Oncol Nurs Forum; 2008 Nov; 35(6):885-7. PubMed ID: 18980919
[No Abstract] [Full Text] [Related]
32. Community-based trial of R-CHOP and maintenance rituximab for intermediate- or high-grade non-Hodgkin lymphoma with first-cycle filgrastim for older patients.
Case DC; Desch CE; Kalman LA; Vongkovit P; Mena RR; Fridman M; Allen B
Clin Lymphoma Myeloma; 2007 Mar; 7(5):354-60. PubMed ID: 17562245
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter cinaedi bacteremia in four renal transplant patients: clinical features and an important suggestion regarding the route of infection.
Imafuku A; Araoka H; Tanaka K; Marui Y; Sawa N; Ubara Y; Takaichi K; Ishii Y; Tomikawa S
Transpl Infect Dis; 2016 Feb; 18(1):132-6. PubMed ID: 26556588
[TBL] [Abstract][Full Text] [Related]
34. Clinical Features of Community-Acquired Helicobacter cinaedi Bacteremia.
Uwamino Y; Muranaka K; Hase R; Otsuka Y; Hosokawa N
Helicobacter; 2016 Feb; 21(1):24-8. PubMed ID: 25997542
[TBL] [Abstract][Full Text] [Related]
35. First case report of thyroid abscess caused by Helicobacter cinaedi presenting with thyroid storm.
Takehara T; Tani T; Yajima K; Watanabe M; Otsuka Y; Koh H
BMC Infect Dis; 2019 Feb; 19(1):166. PubMed ID: 30770725
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiologic and clinical analysis of Helicobacter cinaedi bacteremia in Japan.
Nukui Y; Chino T; Tani C; Sonobe K; Aiso Y; Tohda S; Koike R; Saito R
Helicobacter; 2020 Feb; 25(1):e12675. PubMed ID: 31755167
[TBL] [Abstract][Full Text] [Related]
37. First case of bacteremia caused by Helicobacter cinaedi in a patient with liver cirrhosis: a case report and literature review.
Kamimura K; Kumaki D; Arita M; Kobayashi Y; Mizuno K; Kusama F; Kobayashi M; Abe H; Takahashi Y; Ogawa K; Shinagawa Y; Takeuchi M; Sato Y; Kawai H; Yamagiwa S; Terai S
Clin J Gastroenterol; 2015 Oct; 8(5):306-17. PubMed ID: 26342291
[TBL] [Abstract][Full Text] [Related]
38. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
39. [Three Cases of Bacteremia due to Helicobacter cinaedi Infection and the Usefulness of Gene Analysis of Isolated Bacteria].
Sasahara Y; Noguchi S; Orihashi T; Shimabukuro I; Ogoshi T; Yatera K; Yoshii C; Mukae H
J UOEH; 2015 Dec; 37(4):293-8. PubMed ID: 26667196
[TBL] [Abstract][Full Text] [Related]
40. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
